510(k) K032254
K032254 is an FDA 510(k) premarket notification submitted by Ibl GmbH for the device "IBL C1Q-CIC CIA TEST". The FDA issued a decision of Substantially Equivalent on Aug 29, 2003. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Ibl GmbH has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 29, 2003
- Date Received
- Jul 22, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Complement C1q, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5240
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Ibl GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.